Chelation therapy in liver diseases of childhood: Current status and response

doi:10.4254/wjh.v13.i11.1552

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4463)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

313

WORD

139

HTML

2741

Figures (1-2)

359

Tables (1-4)

224

Sum=3776

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

293

Download

394

Sum=687

Nov 27, 2021 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Nov 27, 2021; 13(11): 1552-1567
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1552

Full Size Figure Download Figure

Figure 1 Pathophysiology of Wilson’s disease. Due to mutation in ATP 7B gene, P type ATPase is defective and copper is not incorporated in ceruloplasmin. Free copper increases in blood and is deposited in liver and extrahepatic sites (brain, kidneys, bones, cornea, RBC).

Citation: Seetharaman J, Sarma MS. Chelation therapy in liver diseases of childhood: Current status and response. World J Hepatol 2021; 13(11): 1552-1567
URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1552.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1552